Just like those New Year’s resolutions that fizzle out by February, the majority of patients prescribed popular weight-loss drugs like Wegovy give up within a year. It’s like starting a gym membership full of enthusiasm and gradually losing interest over time. And the consequences can be costly, not just for their health but also for their wallets. The analysis of U.S. pharmacy claims showed that healthcare costs for these patients skyrocketed as their drug use declined. While the promise of quick weight loss may initially entice patients to try these medications, it seems that long-term adherence is a challenge. But why is this the case? Is it because the side effects outweigh the benefits? Or perhaps users simply don’t see the desired results? Further research may shed light on these questions and help find strategies to improve patient compliance and achieve sustained weight loss. To learn more about this study, delve into the underlying research!
